| 000 | 01509 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517083219.0 | ||
| 264 | 0 | _c20170802 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1527-3350 | ||
| 024 | 7 |
_a10.1002/hep.28529 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChoi, Jonggi | |
| 245 | 0 | 0 |
_aAspirin use and the risk of cholangiocarcinoma. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _c09 2016 |
||
| 300 |
_a785-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 |
_aBile Duct Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMinnesota _xepidemiology |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aGhoz, Hassan M | |
| 700 | 1 | _aPeeraphatdit, Thoetchai | |
| 700 | 1 | _aBaichoo, Esha | |
| 700 | 1 | _aAddissie, Benyam D | |
| 700 | 1 | _aHarmsen, William S | |
| 700 | 1 | _aTherneau, Terry M | |
| 700 | 1 | _aOlson, Janet E | |
| 700 | 1 | _aChaiteerakij, Roongruedee | |
| 700 | 1 | _aRoberts, Lewis R | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 64 _gno. 3 _gp. 785-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.28529 _zAvailable from publisher's website |
| 999 |
_c25793336 _d25793336 |
||